DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Le Cesne A, Ray-Coquard I, Bui BN et al.
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.
Lancet Oncol 2010;
11: 942-949
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.